Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU® study

被引：0
|
作者：
C. Roux
C. Cooper
A. Díez-Pérez
L. Martinez
S. Ortolani
M. Gitlin
G. Möller
S. Shepherd
N. Freemantle
机构：
[1] Paris Descartes University,Department of Rheumatology
[2] University of Southampton,MRC Epidemiology Resource Centre
[3] University of Oxford,NIHR Musculoskeletal BRU
[4] Hospital del Mar IMIM-UAB-RETICEF,Departamento de Medicina
[5] Issy les Moulineaux,Société Française de Médecine Générale
[6] Istituto Auxologico Italiano,Health Economics
[7] Amgen (Europe) GmbH,International Development
[8] Amgen (Europe) GmbH,School of Health and Population Sciences
[9] Biostatistics,Centre d’Evaluation des Maladies Osseuses–Rhumatologie
[10] Amgen Ltd,undefined
[11] University of Birmingham,undefined
[12] Hôpital Cochin,undefined
来源：
Osteoporosis International | 2011年 / 22卷
关键词：
Bone; Dual energy X-ray absorptiometry; Europe; Fractures; Osteopenia; Osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1227 / 1236
页数：9
相关论文
共 50 条
  • [31] Higher prevalence of osteoporosis among women Holocaust survivors.
    Marcus, E
    Menczel, J
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S136 - S136
  • [32] Patterns of Anti-Osteoporosis Medication Use among Women at High Risk of Fracture: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
    Gehlbach, Stephen
    Hooven, Frederick H.
    Wyman, Allison
    Diez-Perez, Adolfo
    Adachi, Jonathan D.
    Luo, Xuemei
    Bushmakin, Andrew G.
    Anderson, Frederick A.
    PLOS ONE, 2013, 8 (12):
  • [33] High medication burden among elderly women with postmenopausal osteoporosis (PMO).
    Bonnick, S
    Amonkar, MM
    Kamel, H
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S93 - S94
  • [34] Osteoporosis medication use among Australian women over two decades
    Stuart, Amanda L.
    Pasco, Julie A.
    Mohebbi, Mohammadreza
    Kotowicz, Mark A.
    Holloway-Kew, Kara L.
    Hosking, Sarah M.
    Williams, Lana J.
    ARCHIVES OF OSTEOPOROSIS, 2020, 15 (01)
  • [35] Osteoporosis medication use among Australian women over two decades
    Amanda L Stuart
    Julie A Pasco
    Mohammadreza Mohebbi
    Mark A Kotowicz
    Kara L Holloway-Kew
    Sarah M Hosking
    Lana J Williams
    Archives of Osteoporosis, 2020, 15
  • [36] PREVALENCE OF SARCOPENIA IN OLDER WOMEN: THE GEELONG OSTEOPOROSIS STUDY
    Pasco, J. A.
    Brennan, S. L.
    Nicholson, G. C.
    Kotowicz, M. A.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S533 - S533
  • [37] Clinical Characteristics and Medication Use among Premenopausal Women with Osteoporosis and Low BMD: The Experience of an Osteoporosis Referral Center
    Cohen, Adi
    Fleischer, Jessica
    Freeby, Matthew J.
    McMahon, Donald J.
    Irani, Dinaz
    Shane, Elizabeth
    JOURNAL OF WOMENS HEALTH, 2009, 18 (01) : 79 - 84
  • [38] Prevalence of osteoporosis and prediction of osteoporosis risk in Italian peri- and postmenopausal women: The detection of osteoporosis risk (DOOR) study
    Agnusdei, D
    Calcagno, V
    Christiansen, C
    Crepaldi, G
    Gennari, C
    Martini, L
    Mazzuoli, GF
    Pasquarelli, V
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (02): : 110 - 122
  • [39] PREVALENCE OF FRAGILITY FRACTURES AND MEDICATION PRESCRIPTION FOR OSTEOPOROSIS IN PATIENTS WITH POLYMYALGIA RHEUMATICA: RESULTS FROM THE PMR COHORT STUDY
    Sokhal, Balamrit Singh
    Hider, Samantha L.
    Paskins, Zoe
    Mallen, Christian D.
    Muller, Sara
    RHEUMATOLOGY, 2021, 60
  • [40] Are there differences among women with postmenopausal osteoporosis depending on the presence of vertebral fractures?
    Cerda, D.
    Peris, P.
    Monegal, A.
    Albaladejo, C.
    Martinez, M.
    Pons, F.
    de Osaba, M. Martinez
    Suris, X.
    Guanabens, N.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S168 - S169
12345